Assessment of psychological distress & COVID-19 vaccination: Comment

Assessment of psychological distress & COVID-19 vaccination: Comment

Bibliographic Details
Main Authors:	Amnuay Kleebayoon, Viroj Wiwanitkit
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Indian Journal of Medical Research
Online Access:	http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2023;volume=157;issue=6;spage=598;epage=598;aulast=Kleebayoon

Similar Items

COVID-19 vaccine type and Guillain-Barré syndrome: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023-01-01)

Comment on "Reactogenicity Study of mRNA COVID-19 Vaccine"
by: Amnuay Kleebayoon, et al.
Published: (2023-07-01)

Willingness of college students to receive COVID-19 heterologous vaccination: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023-01-01)

Interval between doses of COVID-19 vaccine for transplant recipients: A comment
by: Amnuay Kleebayoon, et al.
Published: (2023-01-01)

Potential Adverse Effects of COVID-19 Vaccines on Iranian Healthcare Workers: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023-11-01)

Factors affecting intention of COVID‐19 preventive behaviours including vaccination: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023-09-01)

Comment on Determinants of the Attitude to COVID-19 Vaccine
by: Amnuay Kleebayoon PhD, et al.
Published: (2023-06-01)

Intention to receive COVID-19 vaccine and its health belief model (HBM)-based predictors: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023-08-01)

Comment on published article “Exacerbation of psoriasis after post-COVID-19 vaccine reported in a young female”
by: Amnuay Kleebayoon, et al.
Published: (2023-01-01)

“Acute psychosis induced by mRNA-based COVID-19 vaccine in adolescents: A pediatric case report”: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023-11-01)

Comment on the effectiveness of four SARS-COV-2 vaccines
by: Amnuay Kleebayoon, et al.
Published: (2023-07-01)

COVID-19 infection and vaccination among children
by: Amnuay Kleebayoon, et al.
Published: (2023-12-01)

Hesitancy toward vaccination against COVID-19
by: Amnuay Kleebayoon, et al.
Published: (2023-08-01)

Correspondence on adverse conditions of COVID-19 vaccination
by: Amnuay Kleebayoon, et al.
Published: (2023-04-01)

Side Effects Comparison of Coronavirus Vaccines Among Healthcare Workers: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023-06-01)

Acute interstitial nephritis following COVID-19 vaccination
by: Amnuay Kleebayoon, et al.
Published: (2024-03-01)

COVID-19 vaccine immune response and plasma cell dyscrasia
by: Amnuay Kleebayoon, et al.
Published: (2023-11-01)

Vaccination rates, perceptions, and information sources in inflammatory arthritis: Comment on the article by Lyon et al
by: Amnuay Kleebayoon, et al.
Published: (2023-04-01)

Covid‐19 vaccination landscape in Malta through social media: Correspondence
by: Amnuay Kleebayoon, et al.
Published: (2023-04-01)

Nonstandard alternative COVID-19 vaccination: A current practice that requires reassessment
by: Amnuay Kleebayoon, et al.
Published: (2023-01-01)

Post-Vaccine SARS-CoV-2 Reinfection and Associated Factors Among Health Care Providers: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023-10-01)

Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
by: Amnuay Kleebayoon, et al.
Published: (2023-05-01)

Ophthalmic manifestations of monkeypox: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023-01-01)

THE LANGUAGE MODELS IN HEALTHCARE AND THE ROLE OF CHATGPT: COMMENTS
by: Amnuay Kleebayoon, et al.
Published: (2023-09-01)

Comment on A pedal monkeypox in a HIV patient
by: Amnuay Kleebayoon, et al.
Published: (2023-01-01)

Comments on the article “Monkey pox and female sexual health”
by: amnuay kleebayoon, et al.
Published: (2023-12-01)

Concurrent administration of COVID-19 vaccine and seasonal influenza vaccine: safe according to a small observation
by: Sora Yasri, et al.
Published: (2023-01-01)

Comment on antiviral activities of ginseng and putative benefits against monkeypox virus
by: Amnuay Kleebayoon, et al.
Published: (2023-11-01)

Long-COVID-19 patients and sleep disorders: correspondence
by: Amnuay Kleebayoon, et al.
Published: (2023-12-01)

Dog, cat, pet to human and human to pet COVID‐19 transmission
by: Amnuay Kleebayoon, et al.
Published: (2023-05-01)

Miocarditis aguda tras administración de COVID-19 vacuna: comentario
by: Amnuay Kleebayoon, et al.
Published: (2023-07-01)

Adoption of Artificial Intelligence, Preprints, Open Peer Review, Model Text Recycling Policies, Best Practice in Scholarly Publishing: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023-07-01)

Perceived distress due to nasopharyngeal swab collection: Correspondence
by: Amnuay Kleebayoon, et al.
Published: (2023-06-01)

Pertussis, anti-Bordetella pertussis toxin, vaccination, and clinical surveillance
by: Amnuay Kleebayoon, et al.
Published: (2023-01-01)

Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
by: Amnuay Kleebayoon, et al.
Published: (2023-07-01)

Protective immunity against monkeypox among the local population who has ever got smallpox vaccination in the nonendemic area: An expected rate
by: Amnuay Kleebayoon, et al.
Published: (2023-01-01)

ChatGPT in the field of scientific publication
by: Amnuay Kleebayoon, et al.
Published: (2023-01-01)

AI-generated references in the context of regional anesthesia: Correspondence
by: Amnuay Kleebayoon, et al.
Published: (2023-01-01)

Artificial intelligence in medicine and research
by: Amnuay Kleebayoon, et al.
Published: (2024-01-01)

Monkeypox and dermatological lesions
by: Amnuay Kleebayoon, et al.
Published: (2023-08-01)